JP2006524669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006524669A5 JP2006524669A5 JP2006505808A JP2006505808A JP2006524669A5 JP 2006524669 A5 JP2006524669 A5 JP 2006524669A5 JP 2006505808 A JP2006505808 A JP 2006505808A JP 2006505808 A JP2006505808 A JP 2006505808A JP 2006524669 A5 JP2006524669 A5 JP 2006524669A5
- Authority
- JP
- Japan
- Prior art keywords
- alk
- group
- alkyl
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 cyclopropylmethoxy Chemical group 0.000 claims 31
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 9
- 125000005843 halogen group Chemical group 0.000 claims 8
- 239000002253 acid Substances 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000005336 allyloxy group Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 239000002243 precursor Substances 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000003386 piperidinyl group Chemical group 0.000 claims 5
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 4
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 4
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 4
- 125000006625 (C3-C8) cycloalkyloxy group Chemical group 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 4
- 125000004414 alkyl thio group Chemical group 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 125000006239 protecting group Chemical group 0.000 claims 4
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 4
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims 3
- 125000001931 aliphatic group Chemical group 0.000 claims 3
- 150000001412 amines Chemical class 0.000 claims 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims 3
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 102000019034 Chemokines Human genes 0.000 claims 2
- 108010012236 Chemokines Proteins 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000033115 angiogenesis Effects 0.000 claims 2
- 125000002393 azetidinyl group Chemical group 0.000 claims 2
- 125000004069 aziridinyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 230000006806 disease prevention Effects 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000005059 halophenyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 2
- 125000006173 tetrahydropyranylmethyl group Chemical group 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims 1
- 0 Cc1ccc(*)c(C2*=*NC2)c1 Chemical compound Cc1ccc(*)c(C2*=*NC2)c1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0305213A FR2854158B1 (fr) | 2003-04-25 | 2003-04-25 | Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique |
| FR03/05213 | 2003-04-25 | ||
| PCT/FR2004/000981 WO2004096798A2 (fr) | 2003-04-25 | 2004-04-22 | Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011008854A Division JP2011126891A (ja) | 2003-04-25 | 2011-01-19 | ２−アシルアミノ−４−フェニルチアゾール誘導体の合成中間体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006524669A JP2006524669A (ja) | 2006-11-02 |
| JP2006524669A5 true JP2006524669A5 (https=) | 2007-06-28 |
| JP4839208B2 JP4839208B2 (ja) | 2011-12-21 |
Family
ID=33104460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505808A Expired - Fee Related JP4839208B2 (ja) | 2003-04-25 | 2004-04-22 | ２−アシルアミノ−４−フェニルチアゾール誘導体、それらの製造法およびそれらの治療用途 |
| JP2011008854A Withdrawn JP2011126891A (ja) | 2003-04-25 | 2011-01-19 | ２−アシルアミノ−４−フェニルチアゾール誘導体の合成中間体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011008854A Withdrawn JP2011126891A (ja) | 2003-04-25 | 2011-01-19 | ２−アシルアミノ−４−フェニルチアゾール誘導体の合成中間体 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7504511B2 (https=) |
| EP (1) | EP1656373B1 (https=) |
| JP (2) | JP4839208B2 (https=) |
| KR (1) | KR20060006935A (https=) |
| CN (1) | CN1826339A (https=) |
| AR (1) | AR044070A1 (https=) |
| AT (1) | ATE541843T1 (https=) |
| AU (1) | AU2004234101A1 (https=) |
| BR (1) | BRPI0409716A (https=) |
| CA (1) | CA2521158A1 (https=) |
| CO (1) | CO5640106A2 (https=) |
| CR (1) | CR8037A (https=) |
| EC (1) | ECSP056111A (https=) |
| FR (1) | FR2854158B1 (https=) |
| MA (1) | MA27769A1 (https=) |
| MX (1) | MXPA05011522A (https=) |
| NO (1) | NO20054905L (https=) |
| OA (1) | OA13049A (https=) |
| RS (1) | RS20050769A (https=) |
| RU (1) | RU2348630C2 (https=) |
| TN (1) | TNSN05254A1 (https=) |
| TW (1) | TW200510325A (https=) |
| WO (1) | WO2004096798A2 (https=) |
| ZA (1) | ZA200508608B (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2527B1 (en) * | 2004-04-06 | 2010-03-17 | شركة جانسين فارماسوتيكا ان. في | Derivatives of second-aza-Spiro- (5,5) -andecan and their use as antihistamines |
| JO2676B1 (en) * | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
| FR2872813B1 (fr) | 2004-07-09 | 2007-01-19 | Sanofi Synthelabo | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
| GB0421908D0 (en) * | 2004-10-01 | 2004-11-03 | Angeletti P Ist Richerche Bio | New uses |
| FR2876692B1 (fr) * | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique |
| WO2006074262A1 (en) * | 2005-01-05 | 2006-07-13 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| NZ556628A (en) | 2005-03-08 | 2009-09-25 | Janssen Pharmaceutica Nv | Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
| UA92746C2 (en) * | 2005-05-09 | 2010-12-10 | Акилайон Фармасьютикалз, Инк. | Thiazole compounds and methods of use |
| US8067457B2 (en) | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
| WO2007053499A2 (en) | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of ccr2 |
| WO2007053495A2 (en) * | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of ccr2 |
| FR2895989B1 (fr) * | 2006-01-06 | 2010-04-30 | Sanofi Aventis | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
| EP2059515A2 (en) * | 2006-04-12 | 2009-05-20 | Pfizer Limited | Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| RU2303597C1 (ru) * | 2006-05-12 | 2007-07-27 | Иващенко Андрей Александрович | Фармацевтическая композиция, способы ее получения и применения |
| CN101096363B (zh) * | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
| US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
| CN101534824A (zh) | 2006-11-17 | 2009-09-16 | 艾博特公司 | 作为化学活素受体拮抗剂的氨基吡咯烷 |
| US8153792B2 (en) * | 2007-02-13 | 2012-04-10 | Ab Science | Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors |
| WO2008124000A2 (en) * | 2007-04-02 | 2008-10-16 | Ligand Pharmaceuticals Incorporated | Thiazole derivatives as androgen receptor modulator compounds |
| JP5603770B2 (ja) | 2007-05-31 | 2014-10-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｃｒ２受容体拮抗薬およびその使用 |
| EP2184279B1 (en) * | 2007-07-31 | 2014-11-12 | Shionogi&Co., Ltd. | Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| CN102256963B (zh) | 2008-12-19 | 2014-06-11 | 贝林格尔.英格海姆国际有限公司 | 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺 |
| ES2674275T3 (es) | 2009-12-17 | 2018-06-28 | Centrexion Therapeutics Corporation | Antagonistas del receptor CCR2 y usos de los mismos |
| KR101609856B1 (ko) * | 2010-03-17 | 2016-04-07 | 타이벡스 세라피틱스 코포레이션 | Ｈｅｃ１ 활성의 조절인자 및 이의 방법 |
| WO2011141474A1 (en) | 2010-05-12 | 2011-11-17 | Boehringer Ingelheim International Gmbh | Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| JP5646736B2 (ja) | 2010-05-12 | 2014-12-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用 |
| WO2011144501A1 (en) * | 2010-05-17 | 2011-11-24 | Boehringer Ingelheim International Gmbh | Ccr2 antagonists and uses thereof |
| WO2011147772A1 (en) | 2010-05-25 | 2011-12-01 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists |
| US8962656B2 (en) | 2010-06-01 | 2015-02-24 | Boehringer Ingelheim International Gmbh | CCR2 antagonists |
| EP2731941B1 (en) | 2011-07-15 | 2019-05-08 | Boehringer Ingelheim International GmbH | Novel and selective ccr2 antagonists |
| CN103086859B (zh) * | 2011-11-08 | 2015-11-11 | 清华大学 | 2,4-二羟基-5,6-取代-1-卤代苯衍生物、其合成方法及其应用 |
| US11071736B2 (en) | 2011-11-21 | 2021-07-27 | Taivex Therapeutics Corporation | Modulators of HEC1 activity and methods therefor |
| PT3317270T (pt) | 2015-07-02 | 2020-08-24 | Centrexion Therapeutics Corp | (4-((3r,4r)-3-metoxitetrahidro-pirano-4-ilamino)piperidina-1-il)(5-metil-6-(((2r,6s)-6-(p-tolil)tetrahidro-2h-pirano-2-il)metilamino)pirimidina-4-il)citrato de metanona |
| WO2017019772A1 (en) * | 2015-07-27 | 2017-02-02 | Sanford Burnham Prebys Medical Discovery Institute | Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof |
| WO2019222393A1 (en) * | 2018-05-15 | 2019-11-21 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Neuroprotective compositions and methods of using the same |
| US20210380546A1 (en) * | 2018-10-22 | 2021-12-09 | The Regents Of The University Of California | Vaccine adjuvant |
| WO2020142865A1 (zh) * | 2019-01-07 | 2020-07-16 | 江苏凯迪恩医药科技有限公司 | 一种苯甲酰胺类化合物、中间体、制备方法及应用 |
| US12479816B2 (en) | 2019-02-08 | 2025-11-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | 20-HETE formation inhibitors |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE55034C (de) * | H. KRÜGER in Berlin N., Artilleriestrafse 23 | Zapfenverschlufs für chirurgische Instrumente | ||
| DD55034A (https=) * | ||||
| US3458526A (en) * | 1966-09-26 | 1969-07-29 | Upjohn Co | Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles |
| FR2296497A1 (fr) * | 1974-12-31 | 1976-07-30 | Asselin Robert | Perfectionnement apporte aux fixations de verres optiques sur supports en vue de leur usinage |
| DE2706269C3 (de) * | 1977-02-15 | 1979-08-02 | Th. Goldschmidt Ag, 4300 Essen | Verwendung von Aminderivaten zur Beeinflussung der Theologischen Eigenschaften von Bitumen und bituminösen Massen |
| FR2406634A1 (fr) | 1977-10-19 | 1979-05-18 | Fabre Sa Pierre | Immunostimulants derives d'amino thiazoles |
| JPH0717589B2 (ja) * | 1990-01-22 | 1995-03-01 | ファイザー製薬株式会社 | 新規１，３―ジカルボニル化合物およびその組成物 |
| FR2677356B1 (fr) | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
| WO1993000342A1 (en) | 1991-06-21 | 1993-01-07 | Boehringer Mannheim Italia S.P.A. | 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract |
| GB9816837D0 (en) * | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
| US5656642A (en) * | 1993-04-07 | 1997-08-12 | Otsuka Pharmaceutical Co., Ltd. | Peripheral vasodilating agent containing piperidine derivative as active ingredient |
| DE4326344A1 (de) * | 1993-08-05 | 1995-02-09 | Thomae Gmbh Dr K | Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US6331545B1 (en) * | 1998-12-18 | 2001-12-18 | Soo S. Ko | Heterocycyclic piperidines as modulators of chemokine receptor activity |
| AU2001280187A1 (en) * | 2000-08-28 | 2002-03-13 | Toray Industries, Inc. | Cyclic amine derivatives |
| US7132546B2 (en) | 2000-12-22 | 2006-11-07 | Ishihara Sangyo Kaisha, Ltd. | Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| JP4083422B2 (ja) * | 2000-12-22 | 2008-04-30 | 石原産業株式会社 | アニリン誘導体またはその塩ならびにそれらを含有するサイトカイン産生抑制剤 |
| GB0104050D0 (en) * | 2001-02-19 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| GB0108876D0 (en) * | 2001-04-09 | 2001-05-30 | Novartis Ag | Organic Compounds |
| US20030055263A1 (en) * | 2001-07-11 | 2003-03-20 | Boehringer Ingelheim Pharma Kg | Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production |
| WO2003015778A1 (en) | 2001-08-17 | 2003-02-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| TW200403058A (en) | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| JP2004256429A (ja) * | 2003-02-26 | 2004-09-16 | Sankyo Co Ltd | イソキノリン誘導体 |
| FR2872813B1 (fr) | 2004-07-09 | 2007-01-19 | Sanofi Synthelabo | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
| FR2876692B1 (fr) | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique |
| FR2895989B1 (fr) * | 2006-01-06 | 2010-04-30 | Sanofi Aventis | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
-
2003
- 2003-04-25 FR FR0305213A patent/FR2854158B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-22 JP JP2006505808A patent/JP4839208B2/ja not_active Expired - Fee Related
- 2004-04-22 EP EP04742558A patent/EP1656373B1/fr not_active Expired - Lifetime
- 2004-04-22 BR BRPI0409716-5A patent/BRPI0409716A/pt not_active IP Right Cessation
- 2004-04-22 RU RU2005136663/04A patent/RU2348630C2/ru not_active IP Right Cessation
- 2004-04-22 WO PCT/FR2004/000981 patent/WO2004096798A2/fr not_active Ceased
- 2004-04-22 OA OA1200500305A patent/OA13049A/fr unknown
- 2004-04-22 MX MXPA05011522A patent/MXPA05011522A/es unknown
- 2004-04-22 CN CNA2004800180511A patent/CN1826339A/zh active Pending
- 2004-04-22 AT AT04742558T patent/ATE541843T1/de active
- 2004-04-22 RS YUP-2005/0769A patent/RS20050769A/sr unknown
- 2004-04-22 CA CA002521158A patent/CA2521158A1/fr not_active Abandoned
- 2004-04-22 AU AU2004234101A patent/AU2004234101A1/en not_active Abandoned
- 2004-04-22 KR KR1020057020168A patent/KR20060006935A/ko not_active Ceased
- 2004-04-22 ZA ZA200508608A patent/ZA200508608B/en unknown
- 2004-04-23 AR ARP040101382A patent/AR044070A1/es unknown
- 2004-04-26 TW TW093111632A patent/TW200510325A/zh unknown
-
2005
- 2005-10-06 TN TNP2005000254A patent/TNSN05254A1/en unknown
- 2005-10-11 CR CR8037A patent/CR8037A/es not_active Application Discontinuation
- 2005-10-19 US US11/253,998 patent/US7504511B2/en not_active Expired - Fee Related
- 2005-10-21 EC EC2005006111A patent/ECSP056111A/es unknown
- 2005-10-24 MA MA28569A patent/MA27769A1/fr unknown
- 2005-10-24 NO NO20054905A patent/NO20054905L/no not_active Application Discontinuation
- 2005-10-25 CO CO05108740A patent/CO5640106A2/es not_active Application Discontinuation
-
2009
- 2009-01-27 US US12/360,568 patent/US7777041B2/en not_active Expired - Fee Related
-
2011
- 2011-01-19 JP JP2011008854A patent/JP2011126891A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006524669A5 (https=) | ||
| US11795164B2 (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
| JP6367366B2 (ja) | ４−アミノ−イミダゾキノリン化合物 | |
| RU2005136663A (ru) | Производные 2-ациламино-4-фенилтиазола, их получение и их применение в терапии | |
| US10221181B2 (en) | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors | |
| ES2905755T3 (es) | Derivados de piperidina | |
| JP2010241830A5 (https=) | ||
| MY145465A (en) | Diaminopyrimidines as p2x3 and p2x2/3 antagonists. | |
| CN102762559B (zh) | 二苯基-吡唑并吡啶衍生物、其制备及其作为核受体not调节剂的用途 | |
| TW202002966A (zh) | 稠和雙環C5aR拮抗劑之前藥 | |
| JP2010539110A5 (https=) | ||
| JP2016040288A5 (https=) | ||
| JP2017538682A5 (https=) | ||
| JP2018530539A (ja) | スルフィニルフェニル又はスルホンイミドイルフェニルベンザゼピン | |
| JP2006508935A5 (https=) | ||
| JP2006504658A5 (https=) | ||
| JP2014501724A (ja) | ＪＡＫ阻害剤としてのイミダゾ［１，２−ｂ］ピリダジン誘導体およびイミダゾ［４，５−ｂ］ピリジン誘導体 | |
| WO2012139930A1 (en) | Pyrazolyl-pyrimidine derivatives as kinase inhibitors | |
| CN105899498A (zh) | 用于合成吲哚胺2，3-双加氧酶抑制剂的方法 | |
| KR20140044865A (ko) | Jak 억제제로서의 피리딘-２(１ｈ)-온 유도체 | |
| JP2009523777A5 (https=) | ||
| JP2013521291A5 (https=) | ||
| JP2017510595A5 (https=) | ||
| TW201010990A (en) | New combination-408 | |
| JP2007522142A5 (https=) |